TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26744107

Group type: EXPERIMENTAL
Intervention: Adjuvant interferon alfa‐2b (IFN) therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Completion lymph node dissection (CLND) with IFN
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Completion lymph node dissection (CLND) without IFN
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 0
Study: 25515708

Group type: EXPERIMENTAL
Intervention: Long pulsed 1064 nm Nd:YAG laser (LPND) treatment with three passes at a spot size of 12 mm, 20-24 J/cm² fluence, 12 ms width, and frequency of 2 Hz, for three sessions every four weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control side (untreated)
Number of subjects: 20
Study: 23064597

Group type: EXPERIMENTAL
Intervention: FSBB‐MRA in patients with stroke
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study: 20307245

Group type: EXPERIMENTAL
Intervention: Surgery plus adjuvant 5-fluorouracil (5-FU)-based chemotherapy
Number of subjects: 1006

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: MMR protein negative tumors
Number of subjects: 1006

Group type: EXPERIMENTAL
Intervention: MMR protein positive tumors
Number of subjects: 1006
Study: 18250501

Group type: EXPERIMENTAL
Intervention: Enteral rhEPO 400 U/kg, three times/week, plus FeSO4 3-6 mg/Kg/day (Study group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: FeSO4 only (Control group)
Number of subjects: 16
Study: 16368469

Group type: EXPERIMENTAL
Intervention: Hormone Therapy (HT) - 1mg estradiol + 0.5 mg norethisterone acetate
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 50
Study: 12797703

Group type: EXPERIMENTAL
Intervention: Aminophylline 7.35 mg/kg/day intravenously combined with anti-tuberculosis agents (isoniazid, rifampicin, ethambutol, pyrazinamide)
Number of subjects: 20
Study: 11156459

Group type: EXPERIMENTAL
Intervention: Rectal compliance measurement using a latex rectal balloon filled with water at a rate of 60 ml per minute.
Number of subjects: 974

Group type: EXPERIMENTAL
Intervention: Maximal toleration volume measurement.
Number of subjects: 974
Study: 8979383

Group type: EXPERIMENTAL
Intervention: Self-discrepancy
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Regulatory focus
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Correlates of regulatory focus
Number of subjects: 47
Study: 7930085

Group type: EXPERIMENTAL
Intervention: Pre-admission programme for psychological preparation (videotape, tour, hospital play)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 75
Study: 3294976

Group type: EXPERIMENTAL
Intervention: Inhaled albuterol (2 puffs)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Inhaled metaproterenol (2 puffs)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Inhaled albuterol (1 puff)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Inhaled metaproterenol (1 puff)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 29519283

Group type: EXPERIMENTAL
Intervention: Combined treatment group (lateral position ventilation + vibration sputum drainage)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Simple ventilation group (bilateral discontinuous alternative lateral position ventilation)
Number of subjects: 196
Study: 27614450

Group type: EXPERIMENTAL
Intervention: Tangyiping Granules (TYP) 10 g twice daily for 12 weeks
Number of subjects: 127
Study: 25360512

Group type: EXPERIMENTAL
Intervention: Lemon balm preparation in a beverage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lemon balm preparation in yoghurt
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 23220316

Group type: EXPERIMENTAL
Intervention: Group 1: treated per manufacturers' instructions
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 2: photocured after a delay of 2 minutes
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 3: encapsulated material pre-warmed at 40° C for 90 seconds
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group 4: capsules pre-warmed and photocuring delayed for 2.4 minutes
Number of subjects: 60
Study: 21389794

Group type: EXPERIMENTAL
Intervention: Introduction of small quantities of gluten to infants while breast-feeding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Swedish population-based CD screening study
Number of subjects: 0
Study: 18484971

Group type: EXPERIMENTAL
Intervention: Ezetimibe 40 mg/day
Number of subjects: 27

Group type: COMPARATOR
Intervention: Ezetimibe 10 mg/day
Number of subjects: 27
Study: 16648324

Group type: EXPERIMENTAL
Intervention: Aripiprazole 15 mg/day
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 12859261

Group type: EXPERIMENTAL
Intervention: Timolol maleate/dorzolamide fixed combination (TDFC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Timolol maleate/pilocarpine fixed combination (TPFC)
Number of subjects: 36
Study: 10795432

Group type: EXPERIMENTAL
Intervention: Lipid-lowering treatment
Number of subjects: 583

Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 583
Study: 8971300

Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg once daily, amoxycillin 1000 mg b.d., clarithromycin 250 mg b.d. for 7 days (LAC group)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg once daily, amoxycillin 1000 mg b.d. for 7 days, plus azithromycin 500 mg once daily for 3 days (LAA group)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: LAC group
Number of subjects: 70

Group type: COMPARATOR
Intervention: LAA group
Number of subjects: 70
Study: 1628727

Group type: EXPERIMENTAL
Intervention: Inhaled bradykinin
Number of subjects: 8

Group type: COMPARATOR
Intervention: Inhaled histamine
Number of subjects: 8
Study: 6441544

Group type: EXPERIMENTAL
Intervention: Nicardipine (mean dose: 69.4 mg per day, given three times a day)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 31612844

Group type: EXPERIMENTAL
Intervention: State Entropy (SE) between 40 and 50
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fresh Gas Flow for 10 minutes (group T)
Number of subjects: 90

Group type: COMPARATOR
Intervention: 0.8 Ratio of End-Expired Agent Concentration to Inspired Agent Concentration (group R)
Number of subjects: 90
Study: 29103661

Group type: EXPERIMENTAL
Intervention: Multidisciplinary disease management program (MDMP) with discharge education, physical training, follow-up visits and telephone calls for 180 days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Multidisciplinary disease management program (MDMP)
Number of subjects: 62
Study: 27577516

Group type: EXPERIMENTAL
Intervention: Split-bolus spectral MDCT with virtual unenhanced imaging (1.5 mL/kg body weight, 4 mL/s flow rate)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional tri-phasic enhanced CT (1.5 mL/kg body weight, 4 mL/s flow rate)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Split-bolus spectral MDCT
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional tri-phasic enhanced CT
Number of subjects: 90
Study: 24668572

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Interval Training (MIIT)
Number of subjects: 10
Study: 22801348

Group type: EXPERIMENTAL
Intervention: Penicillin
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 470

Group type: COMPARATOR
Intervention: Initial (day 0) RPR titer
Number of subjects: 470
Study: 20228281

Group type: EXPERIMENTAL
Intervention: Choice set size of 2, 5, 10, and 16 plans
Number of subjects: 0
Study: 17426069

Group type: EXPERIMENTAL
Intervention: Remifentanil at 0.3 microg kg‐1 min‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Remifentanil at 0.4 microg kg‐1 min‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol target-controlled infusion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Phenylephrine bolus
Number of subjects: 40
Study: 15746195

Group type: EXPERIMENTAL
Intervention: Controlled ovarian hyperstimulation (COH)
Number of subjects: 1240
Study: 12521450

Group type: EXPERIMENTAL
Intervention: Forceps
Number of subjects: 442

Group type: COMPARATOR
Intervention: Vacuum
Number of subjects: 442
Study: 9452153

Group type: EXPERIMENTAL
Intervention: Rate Response Optimization (OPT)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Fixed Activity Rate Response Programming (FIXED)
Number of subjects: 37
Study: 9097797

Group type: EXPERIMENTAL
Intervention: Intraoperative suture adjustment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Postoperative suture adjustment
Number of subjects: 25
Study: 2576200

Group type: EXPERIMENTAL
Intervention: Mepindolol (20 mg/9.8 cm2 patch)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg/9.8 cm2 patch)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 23483

Group type: EXPERIMENTAL
Intervention: oral allopurinol
Number of subjects: 16

Group type: COMPARATOR
Intervention: sublingual procaine adenylate
Number of subjects: 16
Study: 30843038

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 212

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study: 28808905

Group type: COMPARATOR
Intervention: 801-mg tablet (fasted state)
Number of subjects: 44

Group type: COMPARATOR
Intervention: 801-mg tablet (fed state)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Capsules (fasted state)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Capsules (fed state)
Number of subjects: 44
Study: 26336692

Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) follow-up system, 5 automated calls over 12 months
Number of subjects: 1608

Group type: EXPERIMENTAL
Intervention: Interactive Voice Response (IVR) follow-up system
Number of subjects: 1608

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1608
Study: 23579036

Group type: EXPERIMENTAL
Intervention: Ozonated oil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Hyaluronic acid gel
Number of subjects: 30
Study: 21195293

Group type: EXPERIMENTAL
Intervention: Saam acupuncture
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 6
Study: 19372193

Group type: EXPERIMENTAL
Intervention: FOBT screening
Number of subjects: 10054
Study: 16330517

Group type: EXPERIMENTAL
Intervention: Post-operative radiotherapy (n = 208)
Number of subjects: 400

Group type: COMPARATOR
Intervention: No post-operative radiotherapy (n = 192)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Post-operative radiotherapy
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Local recurrence
Number of subjects: 400

Group type: COMPARATOR
Intervention: No local recurrence
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Post-treatment follow-up and investigation
Number of subjects: 400
Study: 15320998

Group type: EXPERIMENTAL
Intervention: Game Group (new technologies + motivational game)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (new technologies alone)
Number of subjects: 40
Study: 11252695

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (4 capsules/day, each containing 250 mg of L‐ascorbic acid, 100 IU of dl‐a‐tocopherol acetate, and 150 mg of alpha‐lipoic acid)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation
Number of subjects: 18
Study: 9276791

Group type: EXPERIMENTAL
Intervention: Acidophilus milk containing strains B, N1, and E
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Acidophilus milk containing strain N1
Number of subjects: 11

Group type: COMPARATOR
Intervention: Acidophilus milk containing strain ATCC 4356
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control reduced-fat (2% fat) milk
Number of subjects: 11
Study: 8272392

Group type: EXPERIMENTAL
Intervention: Simple out‐patient treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive physical training
Number of subjects: 0
Study: 3323420

Group type: EXPERIMENTAL
Intervention: deprenyl
Number of subjects: 16

Group type: COMPARATOR
Intervention: Madopar alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Madopar with anti-cholinergics
Number of subjects: 16
Study: 30499426

Group type: EXPERIMENTAL
Intervention: Daily broccoli consumption (200 g cooked broccoli and 20 g raw daikon radish for 15 days, 100 g broccoli and 10 g daikon radish on day 16)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control diet with no broccoli (NB) for 16 days
Number of subjects: 18
Study: 27600862

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 918

Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 918

Group type: COMPARATOR
Intervention: Canagliflozin (100 mg and 300 mg)
Number of subjects: 918

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 918
Study: 23316683

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate-based mouthrinse
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Cetilpiridinium-based mouthrinse
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sterile tap water (control group)
Number of subjects: 16
Study: 22987467

Group type: EXPERIMENTAL
Intervention: Micro-education programme
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (standard instructions)
Number of subjects: 200
Study: 19995617

Group type: EXPERIMENTAL
Intervention: Show Your Work (SYW) system turned 'on'
Number of subjects: 50

Group type: COMPARATOR
Intervention: Show Your Work (SYW) system turned 'off'
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Survey of pharmacies regarding SYW
Number of subjects: 50
Study: 18760124

Group type: COMPARATOR
Intervention: DDD (control group, all OFF)
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: DDDRP (MVP + PAP + ATP ON)
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: MVP group (only MVP ON)
Number of subjects: 1300
Study: 16364933

Group type: EXPERIMENTAL
Intervention: Selective decontamination of the digestive tract (SDD) oral gel
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 12718756

Group type: EXPERIMENTAL
Intervention: Strain rate propagation velocity in patients with treated hypertension
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Flow propagation velocity in patients with treated hypertension
Number of subjects: 25

Group type: COMPARATOR
Intervention: Strain rate propagation velocity
Number of subjects: 25

Group type: COMPARATOR
Intervention: Flow propagation velocity
Number of subjects: 25

Group type: COMPARATOR
Intervention: Ratio between peak mitral flow velocity / strain rate propagation velocity
Number of subjects: 25
Study: 10809913

Group type: EXPERIMENTAL
Intervention: Dyslexic subjects
Number of subjects: 30

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 30
Study: 8813907

Group type: EXPERIMENTAL
Intervention: Indapamide (IND) 2.5 mg daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT) 50 mg daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCT) 12.5 mg and 25 mg daily
Number of subjects: 12
Study: 14621725

Group type: EXPERIMENTAL
Intervention: ganciclovir, 5 mg/kg twice daily (n = 12)
Number of subjects: 23

Group type: COMPARATOR
Intervention: no treatment (n = 11)
Number of subjects: 23
Study: 4019541

Group type: EXPERIMENTAL
Intervention: Cefazolin (25 mg/kg IV)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cefamandole (25 mg/kg IV)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cefoxitin (25 mg/kg IV)
Number of subjects: 30
Study: 29513036

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Supine rest (Control)
Number of subjects: 56
Study: 29933528

Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with CZBG (4 g, twice daily)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Chemotherapy plus placebo
Number of subjects: 235
Study: 25180798

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate 20 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate 50 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate 70 mg
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Armodafinil 250 mg
Number of subjects: 100
Study: 22562731

Group type: EXPERIMENTAL
Intervention: Jogging Stroller with 11.36 kg (JS1)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Jogging Stroller with 22.72 kg (JS2)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No Jogging Stroller (NoJS)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Self-paced trials with Jogging Stroller (JS1 and JS2)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Self-paced trials without Jogging Stroller (NoJS)
Number of subjects: 27
Study: 20021709

Group type: EXPERIMENTAL
Intervention: Reinstated context with rosemary
Number of subjects: 0

Group type: COMPARATOR
Intervention: Switched context with lemon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Odour-based mood induction with rosemary
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Odour distinctiveness with rosemary
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 0
Study: 18564805

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Perilaryngeal Airway (CobraPLA, PLA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: All groups (LMA, LT, PLA)
Number of subjects: 90
Study: 16162042

Group type: EXPERIMENTAL
Intervention: Pool Cool sun safety program
Number of subjects: 375

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 375
Study: 12386036

Group type: EXPERIMENTAL
Intervention: Oral pristinamycin
Number of subjects: 289

Group type: COMPARATOR
Intervention: Intravenous then oral penicillin
Number of subjects: 289
Study: 10188706

Group type: EXPERIMENTAL
Intervention: Infant-focus cognitive instruction
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Self-focus cognitive instruction
Number of subjects: 54

Group type: COMPARATOR
Intervention: Mother-infant interaction
Number of subjects: 54

Group type: COMPARATOR
Intervention: Mother-boyfriend interaction
Number of subjects: 54
Study: 7589027

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg) in sauna sessions
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Captopril (12.5 mg) in sauna sessions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo in sauna sessions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo in control sessions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Captopril (12.5 mg) in control sessions
Number of subjects: 8

Group type: COMPARATOR
Intervention: Propranolol (40 mg) in control sessions
Number of subjects: 8
Study: 2124433

Group type: EXPERIMENTAL
Intervention: surgery + MMC + 5‐FU (chemotherapy)
Number of subjects: 819

Group type: EXPERIMENTAL
Intervention: surgery + MMC + 5‐FU + OK‐432 or PSK (immunochemotherapy)
Number of subjects: 819

Group type: COMPARATOR
Intervention: surgery alone (control group)
Number of subjects: 819
Study: 7314008

Group type: EXPERIMENTAL
Intervention: 1 mg/kg aminophylline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 6 mg/kg aminophylline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High theophylline concentrations
Number of subjects: 10
Study: 30846366

Group type: EXPERIMENTAL
Intervention: Exogenously administered oxytocin (single dose)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Endogenous oxytocin levels
Number of subjects: 38
Study: 29167034

Group type: EXPERIMENTAL
Intervention: BEWARE body awareness training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 40
Study: 26552906

Group type: EXPERIMENTAL
Intervention: Ultrasound muscle thickness (MT) measurements
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Regression-based prediction equations for estimating DXA-derived aLM
Number of subjects: 102
Study: 23381803

Group type: EXPERIMENTAL
Intervention: ALKS-33
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 21547860

Group type: EXPERIMENTAL
Intervention: Pilates-based mat exercises (n = 38)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (n = 24)
Number of subjects: 62
Study: 19735037

Group type: EXPERIMENTAL
Intervention: Mastery goal condition
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Performance-approach goal condition
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Performance-avoidance goal condition
Number of subjects: 102

Group type: COMPARATOR
Intervention: All three goal conditions
Number of subjects: 102
Study: 17893574

Group type: EXPERIMENTAL
Intervention: Oral gabapentin 800 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15031278

Group type: EXPERIMENTAL
Intervention: Peer education program
Number of subjects: 1004

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1004
Study: 11474662

Group type: EXPERIMENTAL
Intervention: Alefacept 0.025 mg/kg
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Alefacept 0.075 mg/kg
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Alefacept 0.150 mg/kg
Number of subjects: 229

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Alefacept
Number of subjects: 229
Study: 9727378

Group type: EXPERIMENTAL
Intervention: Lipopolysaccharide stimulation for 20 hours
Number of subjects: 0

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dialysis patients
Number of subjects: 0
Study: 7508536

Group type: EXPERIMENTAL
Intervention: FK‐506 plus prednisone
Number of subjects: 37

Group type: COMPARATOR
Intervention: Cyclosporine A (CSA) plus prednisone and azathioprine
Number of subjects: 37